Cost-cutting Agfa makes deals to expand healthcare range
This article was originally published in Clinica
Agfa-Gevaert is to shed up to 4,000 jobs across the company - 18% of its workforce - as it implements cost-cutting measures. At the same time, it has announced two deals - the purchase of a minority share in MediVision Medical Imaging and all share capital of Mitra - as part of its strategy of becoming a "leading hospital imaging and informatics provider".
You may also be interested in...
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.
Resilience has raised $800m to develop new technologies to manufacture complex drugs including vaccines, cell therapies and gene therapies.